BSA-85630-29867
2 vaccinations
3 coded responses
17 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 752 / TX
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Registered in v-safe
- 2021-01-08
- 2021-01-09
- 2021-01-11
- 2021-01-13
- 2021-01-21
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-02
- 2021-02-04
- 2021-02-13
- 2021-02-18
- 2021-02-25
-
2021-03-05
Survey response — day 35, dose 2MedDRA: Erythema, Pruritus, Rash — Feeling: GoodFree text: small skin bumps to both arms and legs with redness and itchingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
-
2021-05-03
Survey response — 3 months, dose 2MedDRA: Office visit, Pruritus, Rash, Skin irritation, Skin lesion, Sleep disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Severe generalized itching with rash ,skin irritation and bumps. Was unable to sleep at night due to itching. I had experienced itching in the past that was seasonal but not as severe and with no rash and lesions. I am better now with treatment. · Healthcare visit (other): Saw a dermatologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-01
Survey response — 6 months, dose 2MedDRA: Office visit, Pemphigoid — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: I developed an autoimmune disease called Bullous Pemphoid. Started 1 or 2 weeks after the 2nd dose. I am still under treatment with a dermatologist & taking prednisone 10 md /d and cellcerp 2500 mg / day · Healthcare visit (other): Dermatologist officeMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-01
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-05
-
2021-08-06
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech |
Call center
2 call center cases
2 successful
Free text
Release 5 — day 35, dose 2
Symptoms: small skin bumps to both arms and legs with redness and itching
Release 8 — 3 months, dose 2
Symptoms: Severe generalized itching with rash ,skin irritation and bumps. Was unable to sleep at night due to itching. I had experienced itching in the past that was seasonal but not as severe and with no rash and lesions. I am better now with treatment.
Healthcare visit (other): Saw a dermatologist
Release 9 — 6 months, dose 2
Symptoms: I developed an autoimmune disease called Bullous Pemphoid. Started 1 or 2 weeks after the 2nd dose. I am still under treatment with a dermatologist & taking prednisone 10 md /d and cellcerp 2500 mg / day
Healthcare visit (other): Dermatologist office
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Office visit | ✓ | · | ✓ |
| SD | Pemphigoid | ✓ | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Skin irritation | ✓ | ✓ | ✓ |
| SD | Skin lesion | ✓ | ✓ | ✓ |
| SD | Sleep disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release